International Congress London 2016

Saturday, 03.09.2016 Sunday, 04.09.2016 Monday, 05.09.2016 Tuesday, 06.09.2016 Wednesday, 07.09.2016		Sponsored symposia: Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.

Lung cancer: latest developments in screening and patient management

Lunchtime session
Chairs: Klaus Friedrich Rabe (Großhansdorf, Germany), Jean-Paul Sculier (Brussels, Belgium)
Aims: The aim of this session is to learn about the latest treatments, clinical developments, and thinking in the area of lung cancer screening, management, and treatment.
Target audience: The session will mostly apply to practicing clinicians, oncologists and pulmonologists, but also policymakers and translational scientists.

Download all media

Lung cancer screening: latest developments and unanswered questions Carlijn Van der Aalst (Rotterdam, Netherlands)
New and emerging targeted treatments in advanced lung cancer Fred R. Hirsch (Aurora, United States of America)
Challenges in molecular testing in lung cancer patients with advanced disease Rowena Sharpe (London, United Kingdom), G. Middleton (London, United Kingdom)
Results from the UK Medical Research Council QUARTZ randomised controlled trial in patients with NSCLC Paula Mulvenna (Newcastle upon Tyne, United Kingdom)